Drugs that contain Pazopanib Hydrochloride

1. List of Votrient drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7105530 NOVARTIS Pyrimidineamines as angiogenesis modulators
Oct, 2023

(6 months from now)

Market Authorisation Date: 19 October, 2009

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

VOTRIENT family patents

11

United States

3

Norway

2

Denmark

2

Hong Kong

2

Slovenia

2

Hungary

2

Germany

2

Portugal

2

Spain

2

European Union

1

Israel

1

South Africa

1

Austria

1

Mexico

1

Australia

1

Belgium

1

Brazil

1

Cyprus

1

Korea, Republic of

1

Poland

1

Czech Republic

1

China

1

Luxembourg

1

Japan

1

Canada

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in